mAbxience agrees to produce AstraZeneca COVID-19 vaccine in Argentina

mAbxience entered into an agreement with AstraZeneca to produce the COVID-19 vaccine at its Garín plant in Argentina. The active ingredient will be sent to Mexico for filling, with over 200 million doses supplied to Latin America.

“mAbxience, the biotec company of the Spanish Insud Pharma group, is deeply proud to announce that has entered into an agreement with AstraZeneca to produce a Covid-19 vaccine in Latin America.”chemopharmaceuticals.com

• 1 source
• chemopharmaceuticals.commAbxience enters into an agreement with AstraZeneca to produce Covid-19 vaccine - ChemoTheOMSAug 17, 2019

Summarized from public sources; check the original articles before acting on it.